US firm Mylan NV received a stern warning from the FDA in August for faulty manufacturing practices at three of its India drugmaking plants.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
US firm Mylan NV received a stern warning from the FDA in August for faulty manufacturing practices at three of its India drugmaking plants.
| Subscribe To Our Free Newsletter |
